Palliative nursing care of the patient with cancer-related fatigue

Journal of Hospice and Palliative Nursing

Volumn 13, Issue 5, 2011, Pages 270-278

  Keeney, Cynthia Ellis ^a   Head, Barbara A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

cancer related fatigue; case study; fatigue; palliative care; symptom management

Indexed keywords

EID: 80052649974     PISSN: 15222179     EISSN: 15390705     Source Type: Journal    
DOI: 10.1097/NJH.0b013e318221aa36     Document Type: Review

References (79)

1. Berger AM, Abernethy AP, Atkinson A, et al. Cancer-related fatigue. J Natl Compr Canc Netw. 2010;8(8):904-930.
2. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640-650.
3. Piper B, Cella D. Cancer-related fatigue: Definitions and clinical subtypes. J Natl Compr Canc Netw. 2010;8(8):958-966.
4. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27-43.
5. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: The scale of the problem. Oncologist. 2007;12(1 suppl):4-10.
6. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):40-50.
7. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist. 2000;5(5):353-360.
8. Hartvig P, Aulin J, Hugerth M,Wallenberg S,Wagenius G. Fatigue in cancer patients treated with cytotoxic drugs. J Oncol Pharm Pract. 2006;12(3):155-164.
9. Butt Z, Rosenbloom SK, Abernethy AP, et al. Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw. 2008;6(5):448-455.
10. Mormont MC, Waterhouse J, Bleuzen P, et al. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 2000;6(8):3038-3045.
11. Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage. 2005;30(5):433-442.
12. Hofman M, Hickok JT,MorrowGR, Roscoe JA,Gillies J, Ranson SL. Cancer treatment side effects in breast cancer patients receiving radiation therapy. J Clin Oncol. 2005;23(suppl):705.
13. Nail LM. My get up and go got up and went: Fatigue in people with cancer. J Natl Cancer Inst Monogr. 2004;(32):72-75.
14. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997;34(3 suppl 2):4-12.
15. Hartvig Honore P. Molecular mechanisms in cytotoxic drug induced fatigue. Ann Pharm Fr. 2010;68(2):76-81.
16. Morrow GR. Cancer-related fatigue: Causes, consequences, and management. Oncologist. 2007;12(1 suppl):1-3.
17. Forlenza MJ, Hall P, Lichtenstein P, Evengard B, Sullivan PF. Epidemiology of cancer-related fatigue in the Swedish twin registry. Cancer. 2005;104(9):2022-2031.
18. Hung R, Krebs P, Coups EJ, et al. Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J Pain Symptom Manage. 2011;41(2):426-435.
19. Donovan KA, Jacobsen PB. Fatigue, depression, and insomnia: Evidence for a symptom cluster in cancer. Semin Oncol Nurs. 2007;23(2):127-135.
20. Walsh D, Rybicki L. Symptom clustering in advanced cancer. Support Care Cancer. 2006;14(8):831-836.
21. Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone. 2004;6 suppl 1D:S15-S21.
22. Hamilton J, Butler L, Wagenaar H, et al. The impact and management of cancer-related fatigue on patients and families. Can Oncol Nurs J. 2001;11(4):192-198.
23. Kwon YC, Yun YH, Lee KH, et al. Symptoms in the lives of terminal cancer patients: Which is the most important? Oncology. 2006;71(1-2):69-76.
24. Spelten ER, Verbeek JHAM, Uitterhoeve ALJ, et al. Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer. 2003;39(11):1562-1567.
25. Yennurajalingam S, Bruera E. Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA. 2007;297(3):295-304.
26. Neuenschwander H. Fatigue. In: Michael J, Fisch EB, ed. Handbook of Advanced Cancer Care. New York: Cambridge University Press; 2003:374-381.
27. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58-69.
28. Bakshi R. Fatigue associated with multiple sclerosis: Diagnosis, impact and management. Mult Scler. 2003;9(3):219-227.
29. Stone P, Richards M, A'Hern R, Hardy J. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000;11(5):561-567.
30. Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care. 1995;11(1):27-32.
31. Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R. Fatigue in advanced cancer: A prospective controlled cross-sectional study. Br J Cancer. 1999;79(9-10):1479-1486.
32. Radbruch L, Strasser F, Elsner F, et al. Fatigue in palliative care patientsVan EAPC approach. Palliat Med. 2008;22(1):13-32.
33. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park). 2000;14(11A):151-161.
34. Passik SD, Kirsh KL, Donaghy K, Holtsclaw E, Theobald T, Cella D. Patient-related barriers to fatigue communication: Initial validation of the Fatigue Management Barriers Questionnaire. J Pain Symptom Managem. 2002;24(5):481-493.
35. Borneman T, Koczywas M, Sun V, et al. Effectiveness of a clinical intervention to eliminate barriers to pain and fatigue management in oncology. J Palliat Med. 2011;14(2):197-205.
36. Borneman T, Ppiper BF, Sun VC, Koczywas M, Uman G, Ferrell B. Implementing the fatigue guidelines at one NCCN member institution: Process and outcomes. J Natl Compr Canc Netw. 2007; 5(10):1092-1101.
37. Borneman T, Koczywas M, Sun VC, Piper BF, Uman G, Ferrell B. Reducing patient barriers to pain and fatigue management. J Pain Symptom Manage. 2010;39(3):486-501.
38. Piper BF, Borneman T, Sun VC, et al. Cancer-related fatigue: Role of oncology nurses in translating National Comprehensive Cancer Network assessment guidelines into practice. Clin J Oncol Nurs. 2008;12(5 suppl):37-47.
39. Von Roenn JH, Paice JA. Control of common, non-pain cancer symptoms. Semin Oncol. 2005;32(2):200-210.
40. Winningham ML, Nail LM, BurkeMB, et al. Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum. 1994; 21(1):23-36.
41. WinninghamML. The puzzle of fatigue: How do you nail pudding to the wall? In:Winningham ML, Barton-Burke M, eds. Fatigue in Cancer: A Multidimensional Approach. Sudbury, MA: Jones & Bartlett; 2000:31-53.
42. Winningham ML. Strategies for managing cancer-related fatigue syndrome: A rehabilitation approach. Cancer. 2001;92(4 suppl): 988-997.
43. Minton O, Stone P. A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol. 2009; 20(1):17-25.
44. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63-74.
45. Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsychiatry. 2003;8(4):229-240.
46. Campbell ML, Happ MB, Hultman T, et al. The HPNA Research Agenda for 2009-2012. J Hosp Palliat Nurs. 2009;11(1):10-18.
47. Bruera E, ElOsta B, Valero V, et al. Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J ClinOncol. 2007;25(23):3475-3481.
48. Escalante C. Cancer-related fatigue: Treatment. In: Hesketh PJ, Savarese D, eds. UpToDate. Watham, MA: UpToDate, Inc; 2010. http://www.uptodate.com/ contents/cancer-related-fatiguetreatment? source=search- result&selectedTitle=10%7E71.
49. Spathis A, Dhillan R, Booden D, Forbes K, Vrotsou K, Fife K. Modafinil for the treatment of fatigue in lung cancer: A pilot study. Palliat Med. 2009;23(4):325-331.
50. Methylphenidate: Drug information. UpToDate (online database). Updated 2011. http://www.uptodate.com/contents/methylphenidate-drug-information?source= search-result&selectedTitle=1%7E71. AccessedMarch 3, 2011.
51. Hanna A, Sledge G, Mayer ML, et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer. 2006;14(3):210-215.
52. Methylphenidate. Elsevier, Inc; 2011. http://www.mdconsult. com.echo.louisville.edu/das/pharm/body/235332037-4/0/full/391. Accessed February 11, 2011.
53. Portenoy RK, Mehta Z, Ahmed E. Cancer pain management with opioids: Prevention and management of side effects. In: Hesketh PJ, Savarese D, eds. UpToDate. Watham, MA: UpToDate, Inc; 2010.
54. Homsi J, Walsh D, Nelson KA. Psychostimulants in supportive care. Support Care Cancer. 2000;8(5):385-397.
55. Bruera E, Chadwick S, Brenneis C, Hanson J, MacDonald R. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep. 1987;71(1):67-70.
56. Harris J-D. Fatigue in chronically ill patients. Curr Opin Support Palliat Care. 2008;2(3):180-186.
57. Breitbart W, Alici Y. Pharmacologic treatment options for cancerrelated fatigue: Current state of clinical research. Clin JOncol Nurs. 2008;12(5 suppl):27-36.
58. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep. 1985;69(7-8): 751-754.
59. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer. 1974; 33(6):1607-1609.
60. Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol. 1989; 25(12):1817-1821.
61. Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol. 1989;25(12):1823-1829.
62. Ohnuma T. Complications of cancers and their treatment. In: Kufe DW, Frei III E, Holland JF, et al, eds. Holland-Frei Cancer Medicine. 8th ed. Shelton, CT: People's Medical Publishing House-USA; 2010.
63. Barsevick A, Beck SL, DudleyWN, et al. Efficacy of an intervention for fatigue and sleep disturbance during cancer chemotherapy. J Pain Symptom Manage. 2010;40(2):200-216.
64. Barsevick AM, Dudley W, Beck S, Sweeney C,Whitmer K, Nail L. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100(6):1302-1310.
65. Yates P, Aranda S, Hargraves M, et al. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2005;23(25):6027-6036.
66. Given B, Given CW, McCorkle R, et al. Pain and fatigue management: Results of a nursing randomized clinical trial. Oncol Nurs Forum. 29(6):949-956.
67. Johnson JE, Nail LM, Lauver D, King KB, Keys H. Reducing the negative impact of radiation therapy on functional status. Cancer. 61(1):46-51.
68. Durstine JL, Moore GE, Painter PL, Roberts SO, eds. ACSM's Exercise Management for Persons With Chronic Diseases and Disabilities. Champaign, IL: Human Kinetics; 2009.
69. Mock V. Fatigue management: Evidence and guidelines for practice. Cancer. 2001;92(6 suppl):1699-1707.
70. Dimeo F, Schwartz S, Wesel N, Voigt A, Thiel E. Effects of an endurance and resistance exercise program on persistent cancerrelated fatigue after treatment. Ann Oncol. 2008;19(8):1495-1499.
71. Schmitz KH,Holtzman J, CourneyaKS,Masse LC,Duval S,Kane R. Controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1588-1595.
72. Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr. 2004;(32):112-118.
73. Oldervoll LM, Loge JH, Paltiel H, et al. The effect of a physical exercise program in palliative care: A phase II study. J Pain Symptom Manage. 2006;31(5):421-430.
74. Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. J Cancer Surviv. 2010; 4(2):87-100.
75. Galvao DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol. 2005;23(4):899-909.
76. Davis MP, Walsh D. Mechanisms of fatigue. J Support Oncol. 2010;8(4):164-174.
77. Dean GE, Anderson PR. Fatigue. In: Ferrell BR, Coyle N, eds. Textbook of Palliative Nursing. Oxford: Oxford University Press; 2001:91-100.
78. Ream E. Fatigue in patients receiving palliative care. Nurs Stand. 2007;21(28):49-56; quiz 58.
79. Lindqvist O, Widmark A, Rasmussen BH. Meanings of the phenomenon of fatigue as narrated by 4 patients with cancer in palliative care. Cancer Nurs. 2004;27(3):237-243.